Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
PropertyGuru | PGRU | 24. dec 2024 | 6.70 | 0.00 |
ProPetro | PUMP | 24. dec 2024 | 9.00 | +0.90 |
ProPhase Labs | PRPH | 24. dec 2024 | 0.63 | -0.57 |
ProQR Therapeutics | PRQR | 24. dec 2024 | 2.67 | 0.00 |
PROS | PRO | 24. dec 2024 | 22.55 | +0.18 |
ProShares Bitcoin Strategy ETF | BITO | 24. dec 2024 | 24.25 | +6.64 |
Proshares Ultra FTSE Europe | UPV | 24. dec 2024 | 55.50 | +0.93 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | 24. dec 2024 | 48.12 | -5.46 |
Proshares Ultrashort FTSE Europe | EPV | 24. dec 2024 | 40.86 | -0.76 |
Prospect Capital | PSEC | 24. dec 2024 | 4.36 | +4.81 |
Prospect Capital A Pref | PSEC-A | 24. dec 2024 | 17.93 | +0.06 |
Prosperity Bancshares | PB | 24. dec 2024 | 76.19 | +0.66 |
Protagenic Therapeutics | PTIX | 24. dec 2024 | 0.49 | -8.01 |
Protagonist Therapeutics | PTGX | 24. dec 2024 | 39.30 | -3.20 |
Protalix Bio Therapeutics | PLX | 24. dec 2024 | 1.78 | +2.89 |
Protara Therapeutics | TARA | 24. dec 2024 | 5.17 | +0.39 |
Prothena | PRTA | 24. dec 2024 | 15.40 | +0.46 |
Proto Labs | PRLB | 24. dec 2024 | 40.03 | +1.01 |
Provident Bancorp | PVBC | 24. dec 2024 | 11.55 | +1.40 |
Provident Financial | PROV | 24. dec 2024 | 16.20 | -0.74 |
Provident Financial Services | PFS | 24. dec 2024 | 19.14 | +0.95 |
Prudential ADR | PUK | 24. dec 2024 | 16.02 | +0.31 |
Prudential Financial | PRU | 24. dec 2024 | 119.26 | +0.59 |
Ps International Group | PSIG | 24. dec 2024 | 0.42 | -4.28 |
PSQ Holdings | PSQH | 24. dec 2024 | 3.89 | +2.37 |
Psychemedics | PMD | 24. dec 2024 | 2.67 | 0.00 |
Psyence Biomedical | PBM | 24. dec 2024 | 2.43 | +2.10 |
PT Telkom Indonesia (Persero) Tbk ADR | TLK | 24. dec 2024 | 16.38 | +1.61 |
PTC | PTC | 24. dec 2024 | 187.10 | +1.00 |
PTC Therapeutics | PTCT | 24. dec 2024 | 45.35 | -0.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.